Viracta Therapeutics Ownership 2024 | Who Owns Viracta Therapeutics Now?
Institutional Ownership
22.95%
Insider Ownership
2.84%
Retail Ownership
74.21%
Institutional Holders
40.00
Viracta Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 9.19% | 0.06% | 3,614,662 | - | - | 1,965,292 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.95% | - | 1,161,280 | - | - | 631,388 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 1.75% | 0.08% | 689,709 | - | - | 374,995 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.04% | 0.00% | 407,299 | -13,127 | -3.12% | 221,448 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 0.73% | 0.07% | 288,571 | - | - | 156,896 | Jun 30, 2024 |
| BLACKROCK INC. | 0.69% | - | 273,297 | -30,683 | -10.09% | 148,592 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.69% | - | 270,773 | 18,072 | 7.15% | 147,258 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.55% | 0.00% | 217,699 | 15,200 | 7.51% | 118,363 | Jun 30, 2024 |
| MORGAN STANLEY | 0.34% | - | 134,544 | 16,528 | 14.00% | 73,152 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 74,000 | - | - | 40,234 | Jun 30, 2024 |
| STATE STREET CORP | 0.17% | - | 65,867 | - | - | 35,812,000 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.16% | 0.00% | 61,601 | -1,805 | -2.85% | 33,492 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.10% | - | 38,104 | -86 | -0.23% | 20,717,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.08% | 0.00% | 30,789 | 30,789 | 100.00% | 17,000 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.07% | 0.00% | 27,417 | -336,680 | -92.47% | 14,907 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.05% | 0.00% | 19,201 | 2,213 | 13.03% | 10,440 | Jun 30, 2024 |
| INSPIRION WEALTH ADVISORS, LLC | 0.04% | 0.00% | 15,000 | - | - | 8,156 | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | 0.04% | 0.00% | 15,000 | -2,500 | -14.29% | 8,156 | Jun 30, 2024 |
| HOYLECOHEN, LLC | 0.04% | 0.00% | 14,000 | - | - | 7,612 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 12,652 | 3,763 | 42.33% | 6,883 | Jun 30, 2024 |
Viracta Therapeutics's largest institutional shareholder is BVF INC/IL, holding 9.19% of the company's total share outstanding, currently valued at $1.97M. The top 10 institutional shareholders own together 18.14% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 1.75% | 0.08% | 689,709 | - | - | 374,995 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 0.73% | 0.07% | 288,571 | - | - | 156,896 | Jun 30, 2024 |
| BVF INC/IL | 9.19% | 0.06% | 3,614,662 | - | - | 1,965,292 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | 0.02% | 0.00% | 7,272 | - | - | 3,954 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.04% | 0.00% | 407,299 | -13,127 | -3.12% | 221,448 | Jun 30, 2024 |
| WEALTHTRUST AXIOM LLC | 0.03% | 0.00% | 11,396 | - | - | 6,196 | Jun 30, 2024 |
| INSPIRION WEALTH ADVISORS, LLC | 0.04% | 0.00% | 15,000 | - | - | 8,156 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.08% | 0.00% | 30,789 | 30,789 | 100.00% | 17,000 | Jun 30, 2024 |
| RP MANAGEMENT, LLC | 0.01% | 0.00% | 3,700 | - | - | 1,998 | Jun 30, 2024 |
| TRUST CO OF TOLEDO NA /OH/ | 0.03% | 0.00% | 12,317 | - | - | 6,697 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 74,000 | - | - | 40,234 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.05% | 0.00% | 19,201 | 2,213 | 13.03% | 10,440 | Jun 30, 2024 |
| HOYLECOHEN, LLC | 0.04% | 0.00% | 14,000 | - | - | 7,612 | Jun 30, 2024 |
| IAG WEALTH PARTNERS, LLC | 0.01% | 0.00% | 3,000 | - | - | 1,631 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.55% | 0.00% | 217,699 | 15,200 | 7.51% | 118,363 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.07% | 0.00% | 27,417 | -336,680 | -92.47% | 14,907 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 12,652 | 3,763 | 42.33% | 6,883 | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | 0.04% | 0.00% | 15,000 | -2,500 | -14.29% | 8,156 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.16% | 0.00% | 61,601 | -1,805 | -2.85% | 33,492 | Jun 30, 2024 |
| INDIANA TRUST & INVESTMENT MANAGEMENT CO | 0.00% | - | 200 | - | - | 109 | Jun 30, 2024 |
The largest Viracta Therapeutics shareholder by % of total assets is SAMSARA BIOCAPITAL, LLC. The company owns 689.71K shares of Viracta Therapeutics (VIRX), representing 0.08% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIRTU FINANCIAL LLC | 0.08% | 0.00% | 30,789 | 30,789 | 100.00% | 17,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.69% | - | 270,773 | 18,072 | 7.15% | 147,258 | Jun 30, 2024 |
| MORGAN STANLEY | 0.34% | - | 134,544 | 16,528 | 14.00% | 73,152 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.55% | 0.00% | 217,699 | 15,200 | 7.51% | 118,363 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 12,652 | 3,763 | 42.33% | 6,883 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | - | 7,337 | 2,453 | 50.23% | 3,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.05% | 0.00% | 19,201 | 2,213 | 13.03% | 10,440 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 1,690 | 1,595 | 1678.95% | 920 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.03% | - | 12,496 | 225 | 1.83% | 6,785 | Jun 30, 2024 |
| PRIVATE OCEAN, LLC | - | - | 3 | 3 | 100.00% | 2 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 2 | - | - | 1 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 721 | - | - | 392 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | 14 | - | - | 8 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 8 | - | - | 4 | Jun 30, 2024 |
| BARCLAYS PLC | 0.01% | - | 2,668 | - | - | 1,000 | Jun 30, 2024 |
| ADDISON ADVISORS LLC | - | - | 4 | - | - | 3 | Jun 30, 2024 |
| STATE STREET CORP | 0.17% | - | 65,867 | - | - | 35,812,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.95% | - | 1,161,280 | - | - | 631,388 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.03% | - | 10,908 | - | - | 5,000 | Jun 30, 2024 |
| INDIANA TRUST & INVESTMENT MANAGEMENT CO | 0.00% | - | 200 | - | - | 109 | Jun 30, 2024 |
As of Jun 30 2024, Viracta Therapeutics's largest institutional buyer is VIRTU FINANCIAL LLC. The company purchased 30.79K stocks of VIRX, valued at $17.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAI CAPITAL MANAGEMENT | 0.07% | 0.00% | 27,417 | -336,680 | -92.47% | 14,907 | Jun 30, 2024 |
| BLACKROCK INC. | 0.69% | - | 273,297 | -30,683 | -10.09% | 148,592 | Jun 30, 2024 |
| UNITED BANK | - | - | - | -25,200 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.04% | 0.00% | 407,299 | -13,127 | -3.12% | 221,448 | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | 0.04% | 0.00% | 15,000 | -2,500 | -14.29% | 8,156 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -2,068 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.16% | 0.00% | 61,601 | -1,805 | -2.85% | 33,492 | Jun 30, 2024 |
| NBC SECURITIES, INC. | - | - | - | -1,400 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 171 | -214 | -55.58% | 93 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.10% | - | 38,104 | -86 | -0.23% | 20,717,000 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 1.75% | 0.08% | 689,709 | - | - | 374,995 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 0.73% | 0.07% | 288,571 | - | - | 156,896 | Jun 30, 2024 |
| BVF INC/IL | 9.19% | 0.06% | 3,614,662 | - | - | 1,965,292 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | 0.02% | 0.00% | 7,272 | - | - | 3,954 | Jun 30, 2024 |
| WEALTHTRUST AXIOM LLC | 0.03% | 0.00% | 11,396 | - | - | 6,196 | Jun 30, 2024 |
| INSPIRION WEALTH ADVISORS, LLC | 0.04% | 0.00% | 15,000 | - | - | 8,156 | Jun 30, 2024 |
| RP MANAGEMENT, LLC | 0.01% | 0.00% | 3,700 | - | - | 1,998 | Jun 30, 2024 |
| TRUST CO OF TOLEDO NA /OH/ | 0.03% | 0.00% | 12,317 | - | - | 6,697 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 74,000 | - | - | 40,234 | Jun 30, 2024 |
| HOYLECOHEN, LLC | 0.04% | 0.00% | 14,000 | - | - | 7,612 | Jun 30, 2024 |
As of Jun 30 2024, Viracta Therapeutics's biggest institutional seller is MAI CAPITAL MANAGEMENT. The company sold -0.34M shares of VIRX, valued at $14.91K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UNITED BANK | - | - | - | -25,200 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -2,068 | -100.00% | - | Jun 30, 2024 |
| NBC SECURITIES, INC. | - | - | - | -1,400 | -100.00% | - | Jun 30, 2024 |
Viracta Therapeutics's largest sold out institutional shareholder by shares sold is UNITED BANK, sold -25.20K shares, valued at -, as of undefined.
Viracta Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 29,734 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.03% | 2,897 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 74,000 | - | - | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.01% | 32,937 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,563 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 53,640 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,063 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,096,410 | -282,488 | -20.49% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 237,852 | -1,049 | -0.44% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,843 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 28,450 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 26,997 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,841 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,800 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 12,430 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 34,562 | - | - | Jan 31, 2024 |
| Global X Funds | 0.00% | 10,444 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 638 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 19,426 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,200 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 346 | - | - | Dec 31, 2023 |
| LoCorr Investment Trust | 0.00% | 1,722 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 269,701 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 776 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,436 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 124,014 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,674 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 190 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 13,438 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 49,604 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,300 | - | - | Mar 28, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 44,748 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,836 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 216 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 11,001 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 36 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 92,168 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 125,000 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 6,757 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,466 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,968 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,159 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 240 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 16,908 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 5,069 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,543 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 16,604 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 63,591 | -1,672 | -2.56% | Mar 31, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 28,646 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 200 | 80 | 66.67% | Mar 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,991 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,050 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 11,595 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 701 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,703 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,324 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 4,203 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,210 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,758 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,800 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 34 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 4,571 | - | - | Feb 29, 2024 |
Viracta Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 29.73K shares, compromising 0.06% of its total assets.
Viracta Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 40 | -2.44% |
| 31 Mar, 24 | 41 | -6.82% |
| 31 Dec, 23 | 44 | 2.33% |
| 30 Sep, 23 | 43 | 2.38% |
| 30 Jun, 23 | 42 | -14.29% |
| 31 Mar, 23 | 49 | -12.50% |
| 31 Dec, 22 | 56 | -1.75% |
| 30 Sep, 22 | 57 | -5.00% |
| 30 Jun, 22 | 60 | -10.45% |
| 31 Mar, 22 | 67 | 1.52% |
| 31 Dec, 21 | 66 | - |
| 30 Sep, 21 | 66 | 10.00% |
| 30 Jun, 21 | 60 | 30.43% |
| 31 Mar, 21 | 46 | - |
As of 30 Jun 24, 40 institutions are holding Viracta Therapeutics's shares, representing a decrease of -2.44% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 9,025,598 | -3.92% |
| 31 Mar, 24 | 9,393,496 | -3.67% |
| 31 Dec, 23 | 9,751,265 | 0.61% |
| 30 Sep, 23 | 9,692,391 | -2.75% |
| 30 Jun, 23 | 9,966,868 | -18.43% |
| 31 Mar, 23 | 12,218,665 | -1.22% |
| 31 Dec, 22 | 12,370,026 | 0.12% |
| 30 Sep, 22 | 12,354,711 | 8.63% |
| 30 Jun, 22 | 11,372,927 | -13.07% |
| 31 Mar, 22 | 13,082,927 | -7.60% |
| 31 Dec, 21 | 14,158,964 | -8.63% |
| 30 Sep, 21 | 15,495,841 | 15.99% |
| 30 Jun, 21 | 13,359,309 | 34.56% |
| 31 Mar, 21 | 9,928,444 | - |
Viracta Therapeutics (VIRX) has 9.03M shares outstanding as of 30 Jun 24, down -3.92% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 22.95% | 3.88% |
| 31 Mar, 24 | 24.32% | 3.83% |
| 31 Dec, 23 | 25.21% | 3.99% |
| 30 Sep, 23 | 25.14% | 3.74% |
| 30 Jun, 23 | 25.92% | 2.57% |
| 31 Mar, 23 | 31.77% | 2.97% |
| 31 Dec, 22 | 32.73% | 3.05% |
| 30 Sep, 22 | 32.77% | 3.58% |
| 30 Jun, 22 | 30.25% | 2.49% |
| 31 Mar, 22 | 34.85% | 1.77% |
| 31 Dec, 21 | 44.43% | 2.58% |
| 30 Sep, 21 | 41.48% | 3.22% |
| 30 Jun, 21 | 35.89% | 5.04% |
| 31 Mar, 21 | 26.67% | - |
As of 30 Jun 24, Viracta Therapeutics is held by 22.95% institutional shareholders, representing a 3.88% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -23.08% |
| 31 Mar, 24 | 13 | -13.33% |
| 31 Dec, 23 | 15 | -6.25% |
| 30 Sep, 23 | 16 | 45.45% |
| 30 Jun, 23 | 11 | 10.00% |
| 31 Mar, 23 | 10 | -58.33% |
| 31 Dec, 22 | 24 | 20.00% |
| 30 Sep, 22 | 20 | -4.76% |
| 30 Jun, 22 | 21 | -19.23% |
| 31 Mar, 22 | 26 | -7.14% |
| 31 Dec, 21 | 28 | -12.50% |
| 30 Sep, 21 | 32 | -17.95% |
| 30 Jun, 21 | 39 | -9.30% |
| 31 Mar, 21 | 43 | - |
10 institutional shareholders have increased their position in VIRX stock as of 30 Jun 24 compared to 13 in the previous quarter (a -23.08% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | 33.33% |
| 31 Mar, 24 | 6 | -14.29% |
| 31 Dec, 23 | 7 | -12.50% |
| 30 Sep, 23 | 8 | -20.00% |
| 30 Jun, 23 | 10 | -23.08% |
| 31 Mar, 23 | 13 | -7.14% |
| 31 Dec, 22 | 14 | -12.50% |
| 30 Sep, 22 | 16 | -33.33% |
| 30 Jun, 22 | 24 | 9.09% |
| 31 Mar, 22 | 22 | 10.00% |
| 31 Dec, 21 | 20 | 17.65% |
| 30 Sep, 21 | 17 | 70.00% |
| 30 Jun, 21 | 10 | - |
| 31 Mar, 21 | - | - |
8 institutional shareholders have reduced their position in VIRX stock as of 30 Jun 24 compared to 6 in the previous quarter (a 33.33% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 40 | -2.44% | 9,025,598 | -3.92% | 22.95% | 3.88% | 10 | -23.08% | 8 | 33.33% |
| 31 Mar, 24 | 41 | -6.82% | 9,393,496 | -3.67% | 24.32% | 3.83% | 13 | -13.33% | 6 | -14.29% |
| 31 Dec, 23 | 44 | 2.33% | 9,751,265 | 0.61% | 25.21% | 3.99% | 15 | -6.25% | 7 | -12.50% |
| 30 Sep, 23 | 43 | 2.38% | 9,692,391 | -2.75% | 25.14% | 3.74% | 16 | 45.45% | 8 | -20.00% |
| 30 Jun, 23 | 42 | -14.29% | 9,966,868 | -18.43% | 25.92% | 2.57% | 11 | 10.00% | 10 | -23.08% |
| 31 Mar, 23 | 49 | -12.50% | 12,218,665 | -1.22% | 31.77% | 2.97% | 10 | -58.33% | 13 | -7.14% |
| 31 Dec, 22 | 56 | -1.75% | 12,370,026 | 0.12% | 32.73% | 3.05% | 24 | 20.00% | 14 | -12.50% |
| 30 Sep, 22 | 57 | -5.00% | 12,354,711 | 8.63% | 32.77% | 3.58% | 20 | -4.76% | 16 | -33.33% |
| 30 Jun, 22 | 60 | -10.45% | 11,372,927 | -13.07% | 30.25% | 2.49% | 21 | -19.23% | 24 | 9.09% |
| 31 Mar, 22 | 67 | 1.52% | 13,082,927 | -7.60% | 34.85% | 1.77% | 26 | -7.14% | 22 | 10.00% |
| 31 Dec, 21 | 66 | - | 14,158,964 | -8.63% | 44.43% | 2.58% | 28 | -12.50% | 20 | 17.65% |
| 30 Sep, 21 | 66 | 10.00% | 15,495,841 | 15.99% | 41.48% | 3.22% | 32 | -17.95% | 17 | 70.00% |
| 30 Jun, 21 | 60 | 30.43% | 13,359,309 | 34.56% | 35.89% | 5.04% | 39 | -9.30% | 10 | - |
| 31 Mar, 21 | 46 | - | 9,928,444 | - | 26.67% | - | 43 | - | - | - |
Viracta Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Viracta Therapeutics's stock was made by Pomerantz Roger on May 29 2024, selling 9,035 shares at - per share (valued at -).
Viracta Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | - | - |
| Q1 2024 | 6 | 9 | 66.67% |
| Q4 2023 | 5 | 4 | 125.00% |
| Q3 2023 | 6 | 4 | 150.00% |
| Q2 2023 | 12 | 4 | 300.00% |
| Q1 2023 | 7 | 6 | 116.67% |
| Q4 2022 | 4 | 6 | 66.67% |
| Q3 2022 | 5 | 7 | 71.43% |
| Q2 2022 | 14 | 7 | 200.00% |
| Q1 2022 | 10 | 6 | 166.67% |
| Q4 2021 | 6 | 11 | 54.55% |
| Q3 2021 | 3 | 1 | 300.00% |
| Q2 2021 | 3 | 3 | 100.00% |
| Q1 2021 | 11 | 25 | 44.00% |
| Q2 2020 | 10 | 5 | 200.00% |
| Q1 2020 | 3 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 3 | - | - |
| Q2 2019 | 9 | - | - |
| Q1 2019 | 3 | 6 | 50.00% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Viracta Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | 2 | 1 | 200.00% |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 2 | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | 3 | - |
| Q2 2022 | - | 3 | - |
| Q1 2022 | - | 3 | - |
| Q4 2021 | 1 | 6 | 16.67% |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Viracta Therapeutics's stocks.
Viracta Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| EYPT | EyePoint Pharmaceuticals, Inc. |
| BMEA | Biomea Fusion, Inc. |
| TNYA | Tenaya Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ALXO | ALX Oncology Holdings Inc. |
| SQZ | SQZ Biotechnologies Company |
| IGMS | IGM Biosciences, Inc. |
| RLYB | Rallybio Corporation |
| TERN | Terns Pharmaceuticals, Inc. |
| CABA | Cabaletta Bio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| VINC | Vincerx Pharma, Inc. |
| TARA | Protara Therapeutics, Inc. |
| TRVI | Trevi Therapeutics, Inc. |
| LPTX | Leap Therapeutics, Inc. |
| BCYC | Bicycle Therapeutics plc |
| LYRA | Lyra Therapeutics, Inc. |
VIRX Ownership FAQ
Who Owns Viracta Therapeutics?
Viracta Therapeutics is owned by institutional shareholders (22.95%), insiders (2.84%), and public (74.21%). The largest institutional shareholder of Viracta Therapeutics is BVF INC/IL (9.19% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.06% of total shares).
Who are the major institutional shareholders of Viracta Therapeutics?
Viracta Therapeutics's major institutional shareholders are BVF INC/IL, VANGUARD GROUP INC, SAMSARA BIOCAPITAL, LLC, LAURION CAPITAL MANAGEMENT LP, and AISLING CAPITAL MANAGEMENT LP. The top five shareholders own together 15.67% of the company's share outstanding.
How many Viracta Therapeutics shareholders are there?
As of Jun 2024, there are 40 institutional shareholders of Viracta Therapeutics.
What percentage of Viracta Therapeutics is owned by BVF INC/IL?
BVF INC/IL owns 3.61M shares of Viracta Therapeutics, representing 9.19% of the company's total shares outstanding, valued at $1.97M (as of Jun 2024).
What percentage of Viracta Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 1.16M shares of Viracta Therapeutics (VIRX), compromising 2.95% of the company, valued at $631.39K.
What percentage of Viracta Therapeutics is owned by SAMSARA BIOCAPITAL, LLC?
SAMSARA BIOCAPITAL, LLC is the third largest holder of Viracta Therapeutics. The company owns 689.71K of the company's shares outstanding (worth $375K).